Ro07-3953

Pharmaceutical compound From Wikipedia, the free encyclopedia

Ro07-3953 (Diflunordazepam) is a benzodiazepine derivative which is the 2',6'-difluoro derivative of nordazepam. It was invented in the 1970s but was never marketed,[1][2] however it has recently appeared on the market as a designer drug, first reported in Sweden in December 2024.[3][4]

Legal status
Quick facts Legal status, Identifiers ...
Ro07-3953
Legal status
Legal status
Identifiers
  • 7-chloro-5-(2,6-difluorophenyl)-1H-benzo[e][1,4]diazepin-2(3H)-one
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H91ClF2N2O
Molar mass389.35 g·mol−1
3D model (JSmol)
  • C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=C(C=CC=C3F)F
  • InChI=1S/C15H9ClF2N2O/c16-8-4-5-12-9(6-8)15(19-7-13(21)20-12)14-10(17)2-1-3-11(14)18/h1-6H,7H2,(H,20,21)
  • Key:WENMWXYJTWETRE-UHFFFAOYSA-N
Close

See also

References

Related Articles

Wikiwand AI